[Rationale for the use of sodium benzoate in clinical hepatology]
- PMID: 19256146
[Rationale for the use of sodium benzoate in clinical hepatology]
Abstract
Sodium benzoate is widely used in the Alimentary Industry at low doses for its antimicrobial action. It has also been used as a liver function test. The principle is to evaluate the liver capacity for conjugation of glycine to benzoic acid and to form hippuric acid which is excreted in the urine. In hyperammonemic syndromes, secondary to enzymatic deficiency of the urea cicle, sodium benzoate has the property to act as an alternative way of nitrogen excretion to urinary hippurate instead of urea. Recently, it has been proposed as a therapeutic alternative in cirrhotic patients with portal systemic encephalopathy. Historical, biochemical and clinical data which constitute the principles to validate its clinical application in Hepatology are reviewed in this manuscript.
Similar articles
-
[Sodium benzoate in portal-systemic-encephalopathy-induced blood ammonia normalization and clinical improvement. Interim report of a double-blind multicenter trial].Rev Invest Clin. 1990 Jul;42 Suppl:149-54. Rev Invest Clin. 1990. PMID: 19256155 Clinical Trial. Spanish.
-
Adult onset urea cycle disorder in a patient with presumed hepatic encephalopathy.J Clin Gastroenterol. 2008 Feb;42(2):213-4. doi: 10.1097/01.mcg.0000225628.84168.25. J Clin Gastroenterol. 2008. PMID: 18209596
-
Effect of pantothenic acid on hippurate formation in sodium benzoate-treated HepG2 cells.Pediatr Res. 2000 Sep;48(3):357-9. doi: 10.1203/00006450-200009000-00016. Pediatr Res. 2000. PMID: 10960503
-
[Hyperammonemia type II as an example of urea cycle disorder].Wiad Lek. 2006;59(7-8):512-5. Wiad Lek. 2006. PMID: 17209350 Review. Polish.
-
Treatment of portal systemic encephalopathy: standard and new treatments.Rev Invest Clin. 1990 Jul;42 Suppl:141-8. Rev Invest Clin. 1990. PMID: 19256154 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical